[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"social-cognition\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:social-cognition":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,54,82,106,145,171,198,225],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":32,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100651459","neurocomputational-dynamics-of-cooperation-100651459",false,"NCT07759973","Neurocomputational Dynamics of Cooperation","COBRA","Online cohort inclusion criteria:\n\n* English fluency\n* US residency\n* Owner of a desktop or laptop computer\n* Adult aged 18-100\n\nOnline cohort exclusion criteria:\n\n* Participants who have participated in an earlier version of the study\n* Inability to consent\n* Self-reported history of neurological disorder or brain damage\n* Self-endorsed history of psychosis or mania\n\nClinical cohort inclusion criteria:\n\n* Adult aged 20-60 years old\n* English fluency\n* Owner of a smartphone with celluar data\n\nClinical cohort exclusion criteria:\n\n* Inability to consent\n* Self-reported history of neurological disorder or brain damage\n* Clinician-rated psychosis or mania in the last 6 months\n* Current intoxication or withdrawal\n* Estimated IQ \\\u003C 70\n* fMRI safety concerns\n* Pregnancy\n* Lack of stable psychiatric treatment (e.g., medication dosage, therapy modality) for the previous two months\n\nInformant inclusion criteria:\n\n* Adult aged 18+ years old\n* English fluency\n* Owner of a smartphone with celluar data\n* Must have 4+ interactions\u002Fweek with the participant for at least 6 months prior to study baseline\n\nInformant exclusion criteria:\n\n\\- Lack of a smartphone with cellular data at study baseline",true,"ALL","18 Years","100 Years",{"count":21,"type":22},1612,"ESTIMATED","INTERVENTIONAL",[25],"NA","The purpose of this study is to understand brain function, how people make decisions when they interact with others, and how brain function and behavior relate to personality traits.",[28,29,30,31],"Social Cognition","Personality Disorder","Mental Health","Interpersonal Conflict",[30,33,34,35,36,37,38,39,40],"Multi-informant EMA","Neuroimaging","fMRI","Informant","Multi-method","Ecological Momentary Assessment","Self-report","Longitudinal","NOT_YET_RECRUITING","2026-08-06",{"date":44,"type":45},"2026-08-12","ACTUAL",{"date":47,"type":22},"2026-09-01",{"date":49,"type":22},"2031-06-30",{"name":51,"class":52},"University of Pittsburgh","OTHER",1,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":11,"sex":17,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":4,"studyType":23,"phases":66,"briefSummary":67,"conditions":68,"keywords":4,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":53},"100647283","parent-mediated-social-cognition-intervention-for-young-children-with-autism-spectrum-disorder-100647283","NCT07708246","Parent-Mediated Social Cognition Intervention for Young Children With Autism Spectrum Disorder","Efficacy of a Parent-Mediated, Home-Based Structured Play Intervention on Social Cognitive Development in Young Children With Autism Spectrum Disorder: A Non-Randomized Controlled Study","PMSC-ASD","Inclusion Criteria:\n\nChildren：\n\n* Aged 2.5 to 14 years at time of enrollment, with a primary recruitment focus on children aged 3 to 10 years.\n* Meets diagnostic criteria for autism spectrum disorder (ASD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), confirmed by a specialist clinician.\n* Full-scale intelligence quotient (FSIQ) ≥ 70 as assessed by an age-appropriate Wechsler intelligence scale administered.\n* Possesses sufficient verbal ability to engage with structured play-based intervention activities, as judged by the recruiting clinician.\n* Resides with and is cared for by a participating parent or legal guardian who meets the caregiver eligibility criteria below.\n\nCaregiver：\n\n* Is the primary caregiver (parent or legal guardian) of the enrolled child and resides in the same household.\n* Is able and willing to attend an in-person parent training session (approximately 2.5 hours) at the study site prior to intervention commencement.\n* Is able and willing to commit to administering the structured intervention program to the child for a minimum of 30 minutes per day throughout the 6-month intervention period.\n* Is able and willing to participate in monthly online video supervision sessions with the study clinician.\n* Has sufficient literacy and comprehension ability to understand program training materials and follow intervention procedures.\n* Provides written informed consent on behalf of the child and for their own participation prior to any study procedures.\n\nExclusion Criteria:\n\nChildren：\n\n* Known diagnosis of a genetic syndrome associated with ASD or intellectual disability, including but not limited to Fragile X syndrome, Down syndrome, tuberous sclerosis complex, or Rett syndrome.\n* Presence of a neurological disorder, including epilepsy (unless fully controlled with stable medication for ≥ 12 months), acquired brain injury, cerebral palsy, or other significant neurological condition that may confound assessment of social cognition.\n* Uncorrected vision or hearing impairment that would preclude participation in behavioral or eye-tracking assessments.\n* Currently enrolled in another interventional clinical study targeting social cognition, communication, or behavioral outcomes.\n* Any medical, psychiatric, or developmental condition that, in the opinion of the recruiting clinician, would interfere with the child's ability to participate in or benefit from the intervention.\n\nCaregiver：\n\n* Unable to attend the in-person parent training session at the study site due to geographic, occupational, or other constraints.\n* Unable to commit to the daily home-based intervention schedule or monthly online supervision sessions for the full 6-month intervention period.\n* Presence of significant mental health difficulties or other circumstances that, in the opinion of the recruiting clinician, would substantially impair the caregiver's ability to deliver the intervention with adequate fidelity.","4 Years","8 Years",{"count":65,"type":22},60,[25],"This study evaluates the efficacy of the Companion Mind-Drawing Cooperative Game Program, a parent-mediated, home-based structured play intervention targeting social cognitive development in young children with autism spectrum disorder (ASD).\n\nChildren with ASD in the intervention group will receive a structured program in which parents attend an in-person training session (approximately 2.5 hours) at the hospital, where parents are taught to administer a series of researcher-designed cooperative game paradigms at home. Parents then deliver the intervention daily for at least 30 minutes per session over a period of six months. Monthly online video reviews by a clinician provide parents with individualized feedback and guidance to ensure program fidelity and quality.\n\nChildren with ASD in the comparison group will continue to receive usual care and will not receive the program during the study period.\n\nSocial cognitive outcomes - including emotion recognition, theory of mind, empathy, joint attention, self-perception, and social communication - will be assessed at baseline and at 12-month follow-up using behavioral experimental tasks and eye-tracking paradigms. This study aims to provide evidence for the efficacy of a scalable, family-implemented social cognition intervention for young children with ASD.",[69,70,28,71],"Autism","Intervention (Training) Condition","Cognition Improvement","RECRUITING","2026-07-13",{"date":75,"type":45},"2026-07-16",{"date":77,"type":45},"2025-06-01",{"date":79,"type":22},"2028-12-30",{"name":81,"class":52},"Children's Hospital of Fudan University",{"id":83,"slug":84,"hasResults":11,"nctId":85,"briefTitle":86,"officialTitle":86,"acronym":87,"eligibilityCriteria":88,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":89,"targetDuration":4,"studyType":23,"phases":91,"briefSummary":92,"conditions":93,"keywords":95,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":53},"100498716","evaluation-of-social-cognition-in-patient-with-type-1-or-type-2-narcolepsy-versus-patients-with-idiopathic-hypersomnia-100498716","NCT05773872","Evaluation of Social Cognition in Patient With Type 1 or Type 2 Narcolepsy Versus Patients With Idiopathic Hypersomnia","COGNAR","Inclusion Criteria:\n\n* adult patients (\\>\u002F= 18years old)\n* diagnosis of type 1 or type 2 narcolepsy or idiopathic hypersomnia\n* non opposition\n\nExclusion Criteria:\n\n* comorbid psychiatric or neurologic disease\n* patient under 18 years old\n* patient under guardianship, curators or deprived of liberty, refusal of the patient",{"count":90,"type":22},75,[25],"Narcolepsy is a chronic disabling neurologic disorder mainly characterised by excessive daytime sleepiness. Type 1 narcolepsy is associated with a deficit of hypocretin in the cerebrospinal fluid responsible for the cataplexy symptom while type 2 shows a normal hypocretin level and no cataplexy. While the development of narcolepsy is independent of parental social level, narcolepsy has a significant influence on educational level, grading, social outcome, and welfare consequences. Several studies assessed global cognition efficiency, mood, and attention in narcoleptic patients but only a few specifically measured social cognition and mostly without a control group.\n\nIn a population of narcoleptics children, a severe impairment in social cognition is described for 20% of the group, contrary to 2 % for the control group. The literature also depicts some impairments in decision making, somatic and cognitive emotions responses but the emotion recognition seems to be preserved.\n\nA better understanding of the social and cognitive aspects of narcolepsy could lead to a better treatment of the disease in its entirety, including if relevant specific cognitive behavioural therapy.\n\nThe protocol consists in a psychometric evaluation including several questionnaires in order to assess social cognition. It will be proposed to patients with type 1 or type 2 narcolepsy and patients with idiopathic hypersomnia.",[94,28],"Narcolepsy",[94,96],"social cognition","2026-05-28",{"date":99,"type":45},"2026-06-01",{"date":101,"type":45},"2022-11-18",{"date":103,"type":22},"2027-05",{"name":105,"class":52},"Centre Hospitalier Universitaire, Amiens",{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":112,"eligibilityCriteria":113,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":114,"enrollmentInfo":115,"targetDuration":4,"studyType":23,"phases":116,"briefSummary":117,"conditions":118,"keywords":120,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":139,"completionDateStruct":141,"leadSponsor":143,"locationsCount":53},"100637560","using-illusions-to-boost-social-cognition-100637560","NCT07602712","Using Illusions to Boost Social Cognition","Socio-cognitive Benefits of Exposure to Visual Illusions in Patients With Psychotic Disorders","SOLLUSIONS","Inclusion Criteria:\n\n* Aged 18 to 40 years\n* Fluent French speaker\n* Has provided written informed consent\n* For individuals under guardianship (curatorship): inclusion is permitted if the curator is available to assist or advise when needed.\n* Established diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, or brief psychotic disorder according to theDiagnostic and statistical manual of mental disorders (DSM-5-TR) criteria\n* Presence of social cognition impairment, defined by:subjective complaint reported by the participant or identified by care teams regarding difficulties in social interaction and clinical confirmation of observable difficulties (e.g., social withdrawal, misinterpretation of others' intentions, inappropriate social behaviour)\n* Membership or entitlement to a social security plan\n\nExclusion Criteria:\n\n* Clinical state incompatible with participation in group-based activities (e.g., severe psychomotor agitation, severe behavioural disturbance)\n* Concurrent participation in another social cognition remediation program\n* Diagnosis of intellectual disability\n* Insufficient comprehension of French for verbal interaction and test completion\n* Significant change in psychotropic medication within the past month\n* Uncorrectable visual impairment preventing participation\n* Pregnant women\n* Individuals under full guardianship (tutorship)","40 Years",{"count":65,"type":22},[25],"This study aims to explore whether the observation of complex visual objects can help improve social cognition in people living with psychotic disorders. Social cognition refers to the ability to understand what others think, feel, or intend, and plays a key role in social relationships and daily interactions.\n\nMain questions this study aims to answer:\n\n* Does dyadic exposure to complex visual objects improve mental state attribution, as measured by the Faux Pas Test?\n* Does the intervention enhance related domains of social cognition, including implicit intention inference (Hinting Task), interpretation of complex interactions (Movie for the Assessment of Social Cognition, MASC), and reduction of hostile attribution biases (Ambiguous Intentions Hostility Questionnaire, AIHQ)?\n* Are improvements maintained after one month, and do patients who receive the intervention later (waitlist group) show the same benefits once exposed?",[119,28],"Schizophrenia Spectrum Disorders",[121,122,28,123,124,125,126,127,128,129,130,131,132,133,134,135],"Schizophrenia","Psychosis","Mentalizing","Theory of Mind","Cognitive Remediation","Metacognition","Perspective-Taking","Visual Illusions","Viewpoint Illusions","Bottom-Up Intervention","Sensorimotor Rehabilitation","Faux Pas Test","Hinting Task","Social Interaction","Rehabilitation in Psychosis","2026-05-19",{"date":138,"type":45},"2026-05-22",{"date":140,"type":22},"2026-07",{"date":142,"type":22},"2029-02",{"name":144,"class":52},"Hôpital le Vinatier",{"id":146,"slug":147,"hasResults":11,"nctId":148,"briefTitle":149,"officialTitle":150,"acronym":151,"eligibilityCriteria":152,"healthyVolunteers":16,"sex":17,"minAge":62,"maxAge":153,"enrollmentInfo":154,"targetDuration":4,"studyType":23,"phases":156,"briefSummary":157,"conditions":158,"keywords":162,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":163,"lastUpdatePostDateStruct":164,"startDateStruct":166,"completionDateStruct":168,"leadSponsor":170,"locationsCount":53},"100621946","social-cognition-screening-100621946","NCT07377227","Social COgnition Screening","Evaluation of Social Cognition: A New Screening Approach for Autism","ECoS-A","Inclusion Criteria:\n\n* ASD Group:\n* Boys or girls diagnosed with Autism Spectrum Disorder (based on clinical tools and observations)\n* Aged between 4 and 10 years old\n* Affiliation with a social security scheme\n* Informed consent of those with parental authority\n* DT Group:\n* Boys or girls\n* Aged between 4 and 10\n* Attending school in the Hauts-de-France region\n* Affiliation with a social security scheme\n* Consent of those with parental authority\n\nExclusion Criteria:\n\n* For ASD: Uncorrected visual or auditory impairments.\n* For DT: Intellectual disability, neurological or genetic disorders, autistic traits reported by teachers. The discrepancy between actual age and abilities calculated on the basis of standardised test scores","10 Years",{"count":155,"type":22},128,[25],"Social cognition refers to the mental processes involved in social interactions, including social perception, motivation, communication, emotion recognition, and theory of mind. Face perception plays a key role in children's social development, but children with Autism Spectrum Disorder (ASD) tend to look less at social stimuli, especially faces, than typically developing (TD) peers. Eye-tracking studies highlight these visual exploration differences, linked to difficulties in joint attention, emotion recognition, and theory of mind, as well as in executive and memory functions. Standard diagnostic tests often require active participation and sufficient language, which makes assessment challenging for children with ASD and additional cognitive or language impairments.\n\nThis research project investigates how visual activity supports social cognition depending on cognitive and language levels, hypothesizing that eye-tracking can provide useful indicators for ASD screening and diagnosis.",[159,160,28,161],"Eye-tracking","Autism Spectrum Disorder","Diagnosis",[159,160,28,161],"2026-02-04",{"date":165,"type":45},"2026-02-06",{"date":167,"type":22},"2026-02",{"date":169,"type":22},"2028-12",{"name":105,"class":52},{"id":172,"slug":173,"hasResults":11,"nctId":174,"briefTitle":175,"officialTitle":176,"acronym":4,"eligibilityCriteria":177,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":178,"enrollmentInfo":179,"targetDuration":4,"studyType":23,"phases":181,"briefSummary":183,"conditions":184,"keywords":185,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":189,"lastUpdatePostDateStruct":190,"startDateStruct":192,"completionDateStruct":194,"leadSponsor":196,"locationsCount":53},"100564110","early-phase-1-losartan-and-social-processing-100564110","NCT06624904","Losartan and Social Processing","The Effects of Single-dose Losartan on Social Processing in Healthy Adults: a Randomized Controlled Study","Inclusion Criteria:\n\n* Willing and able to provide informed consent\n* Aged 18-50 years\n* Sufficient written and spoken English skills to understand what the study involves, and to complete the questionnaires\n* Non- or light-smoker (5 cigarettes a day, if vaping: less than 50 puffs)\n* BMI between 18 - 30\n\nExclusion Criteria:\n\n* Current DSM-5 axis-I diagnosis (based on SCID results at screening) or history of a severe psychological disorder such as psychotic disorder, bipolar disorder, alcohol or substance abuse, or post-traumatic stress disorder\n* First-degree family member with severe psychiatric illness (including psychosis, bipolar disorder, unipolar psychotic depression).\n* CNS-medication last 6 weeks (including as part of another study)\n* Current blood pressure or other heart medication, including aliskiren and beta blockers)\n* Diagnosis of intravascular fluid depletion or dehydration\n* History of angioedema\n* Impaired kidney function (based on self-report)\n* Very low blood pressure (defined as repeated (at least three consecutive measurements) measures of blood pressure under standardised conditions where either the systolic or the diastolic blood pressure or both are below 90\u002F50 mmHg (in accordance with established standard definitions)\n* Lifetime history of epilepsy or other neurological disorder, as established by a professional diagnosis (e.g. autism, ADHD)\n* Lifetime history of systemic infection, or clinically significant hepatic, cardiac, obstructive respiratory, renal, cerebrovascular, metabolic, endocrine or pulmonary disease or disorder which, in the opinion of the investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study\n* Significant loss of hearing that is not corrected with a hearing device\n* Women: pregnancy (as determined by a urine test, if the participant's pregnancy status is unknown during the in-person visit), breast-feeding","50 Years",{"count":180,"type":22},68,[182],"EARLY_PHASE1","This study explores the effects of single-dose losartan (50mg) versus placebo on social processing in healthy volunteers.",[28],[186,187,188],"Social Processing","Losartan","Renin Angiotensin System","2025-07-23",{"date":191,"type":45},"2025-07-28",{"date":193,"type":45},"2024-08-19",{"date":195,"type":22},"2025-10-01",{"name":197,"class":52},"University of Oxford",{"id":199,"slug":200,"hasResults":11,"nctId":201,"briefTitle":202,"officialTitle":202,"acronym":203,"eligibilityCriteria":204,"healthyVolunteers":16,"sex":17,"minAge":153,"maxAge":205,"enrollmentInfo":206,"targetDuration":4,"studyType":23,"phases":207,"briefSummary":208,"conditions":209,"keywords":214,"overallStatus":72,"whyStopped":4,"lastUpdateSubmitDate":217,"lastUpdatePostDateStruct":218,"startDateStruct":220,"completionDateStruct":222,"leadSponsor":224,"locationsCount":53},"100454185","mri-eye-tracking-pairing-a-tool-for-assessing-social-cognition-in-children-with-asd-100454185","NCT05194254","MRI-Eye Tracking Pairing, a Tool for Assessing Social Cognition in Children With ASD","IRM-ET","Inclusion Criteria:\n\nFor the group of people with Autism Spectrum Disorders (experimental group):\n\n* Age between 10 to 20 years old\n* Diagnosis of ASD (CARS) ≥ 30 performed at inclusion\n* IQ test evaluation (regardless of the result) performed by a trained psychologist\n* Obtaining informed oral and written consent after appropriate information\n* Obtaining informed oral and written consent from the legal guardian after information\n* Be affiliated with social security\n* No contraindication to magnetic resonance imaging\n\nFor the TD (Typical Development) group of people (control group):\n\n* Age between 10 to 20 years old\n* Diagnosis of ASD (CARS) \\\u003C30 performed at inclusion\n* IQ test evaluation (regardless of the result) performed by a trained psychologist\n* Obtaining informed oral and written consent after appropriate information\n* Obtaining informed oral and written consent from the legal guardian after information\n* Be affiliated with social security\n* No contraindication to magnetic resonance imaging\n\nExclusion Criteria:\n\nFor all groups:\n\n* Age outside the range 10 to 20 years\n* Person with a contraindication to MRI (including claustrophobia, pace maker, neurosurgical clips, vascular clips, heart valves, ventriculoperitoneal valves, cochlear implant, neurostimulator, intraocular metal shards, joint prosthesis, etc.)\n* Person suffering from major obesity (\\> 140 kg) not allowing him to enter the tunnel of the MRI machine (diameter \\\u003C70cm)\n* Pregnant or breastfeeding woman\n* Person under guardianship or guardianship or deprived of liberty by a judicial or administrative decision\n\nFor TD people (control group):\n\n* Person with psychiatric disorders such as attention disorder with or without hyperactivity, depression, bipolar disorder and schizophrenia.\n* Person with a neurological history such as epilepsy and \u002F or neurovascular accident.","20 Years",{"count":180,"type":22},[25],"Most studies use static visual percepts that are less representative of joint attention versus an ecological environment. This has the consequence of decreasing the perception of an interaction with a social partner, which is an essential step in achieving joint attention. The originality of this study is to improve the design of visual percepts (in the form of video) in order to mimic an ecological environment as much as possible by using MRI-ET coupling. The second originality of this study is the longitudinal exploration of the neurodevelopment of social cognition in autistic children. Studies by the Redcay and Oberwelland teams observe different activations at different ages. The hypothesis is that the perception of joint attention varies over time in people with ASD. To date, there are no studies to determine the influence of childhood neurodevelopment in autistic people on the perception of joint attention. It would be unprecedented to use the MRI-ET pairing as a tool for assessing social cognition as a function of the development of children with ASD.",[210,211,212,28,213],"ASD","Functional Magnetic Resonance Imaging","Eye Tracking","Joint Attention",[210,215,212,96,216],"Functional magnetic resonance imaging","joint attention","2025-05-22",{"date":219,"type":45},"2025-05-28",{"date":221,"type":45},"2022-01-04",{"date":223,"type":22},"2025-06",{"name":105,"class":52},{"id":226,"slug":227,"hasResults":11,"nctId":228,"briefTitle":229,"officialTitle":230,"acronym":4,"eligibilityCriteria":231,"healthyVolunteers":16,"sex":232,"minAge":62,"maxAge":4,"enrollmentInfo":233,"targetDuration":4,"studyType":235,"phases":4,"briefSummary":236,"conditions":237,"keywords":240,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":245,"lastUpdatePostDateStruct":246,"startDateStruct":248,"completionDateStruct":250,"leadSponsor":252,"locationsCount":4},"100583272","social-cognition-in-dystrophinopathies-and-neurodevelopmental-disorders-100583272","NCT06874166","Social Cognition in Dystrophinopathies and Neurodevelopmental Disorders","Social Cognition in Dystrophinopathies and Neurodevelopmental Disorders. Behavioural and Psychophisiological Measures","Inclusion Criteria:\n\n* Patients diagnosed with Duchenne and Becker muscular dystrophy (genetic and histological diagnosis and clinical diagnosis) (ambulant and non-ambulant).\n* Patients diagnosed with osteogenesis imperfecta.\n* Control group: participants without any neurological or psychiatric disorder\n\nExclusion Criteria:\n\n* presence of comorbid diagnoses,\n* sensory deficit\n* specific condition that could prevent the application of the tests and tasks under study, such as: a) the need for PEG; b) the need for tracheostomy; c) the need for assisted ventilation.\n* cognitive level lower than 60.","MALE",{"count":234,"type":22},45,"OBSERVATIONAL","The primary aim of this observational study is to investigate specific aspects of social cognition in dystrophinopathies. Body awareness, interpersonal distance and emotional processing will be measured in a sample of patients affected by Becker (BMD) and Duchenne (DMD) muscular dystrophy, compared with a sample of patients affected by osteogenesis imperfecta (OI), and both compared with a control sample with typical development.\n\nThe secondary aim is to study cortical activity at rest, by means of electroencephalography (EEG), to explore frequencies and time course of EEG responses. Moreover, the relationship between EEG activity and neuropsychological, dispositional and subjective measures will be explored through correlational analyses.",[238,239,28],"Duchenne \u002F Becker Muscular Dystrophy","Osteogenesis Imperfecta (OI)",[28,241,239,242,243,244],"Duchenne \u002F Becker muscular dystrophy","EEG","Interpersonal distance","Interoception","2025-03-11",{"date":247,"type":45},"2025-03-13",{"date":249,"type":22},"2025-09",{"date":251,"type":22},"2027-12",{"name":253,"class":52},"IRCCS Eugenio Medea"]